Clinical Trial Update: Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a precise therapy in refractory HER2-positive advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: HER2+ Breast Cancer | Phase 3 | Status: UNKNOWN